KATRINA KOZUB: Open Payments
NPI 1508166547 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 109 payments from 20 companies in 2025. Trend: 2023 $1,823 · 2024 $1,700 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $246 |
| ABBVIE INC. | 16 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $190 |
| AstraZeneca Pharmaceuticals LP | 11 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $151 |
| Lilly USA, LLC | 7 | $127 |
| Grifols USA, LLC | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
Products named: TRINTELLIX, XIFAXAN, Prolastin-C Liquid, AIRSUPRA, MOUNJARO, Wegovy, FANAPT, REXULTI.
Industry payments across IN — which companies pay providers there.
